Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
11/20/2008 | WO2008138834A1 Substituted imidazopyridazines as pi3k lipid kinase inhibitors |
11/20/2008 | WO2008138592A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their uses |
11/20/2008 | WO2008138184A1 Derivatives of pyrroloazacycles, the method of making them and the use thereof as inhibitors of protein kinases |
11/20/2008 | WO2008119685A3 Oxazolidine and morpholine carboxamide derivatives as p2x7 modulators |
11/20/2008 | WO2008109382B1 Nucleic acid compounds for inhibiting pkn3 gene expression and uses thereof |
11/20/2008 | WO2008109376B1 Nucleic acid compounds for inhibiting bcr-abl gene expression and uses thereof |
11/20/2008 | WO2008108673A3 Use of a peptide and an analgesic pharmaceutical agent |
11/20/2008 | WO2008065408A3 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
11/20/2008 | WO2008057171A3 4-1 bb ligand in inflammatory diseases |
11/20/2008 | US20080287543 Pharmaceutical composition comprising 5-methyl-2 (2'-chloro-6'-fluoroanillino) phen ylacetic acid |
11/20/2008 | US20080287532 Oxacyclopentene-2 derivatives |
11/20/2008 | US20080287528 Therapeutic methods and compositions involving isoflavones |
11/20/2008 | US20080287525 Pharmaceuticals for treating or preventing oral diseases |
11/20/2008 | US20080287522 reduced or no emetogenic effects ; benzylated phosphodiesterase 4 inhibitors; e.g. Rolipram, Ariflo, Arofylline; preparation by benzylation using benzyl bromide or a derivative; antiinflammatory agents; to treat autoimmune diseases; cystic fibrosis |
11/20/2008 | US20080287518 Use of a Benzoyl Derivative of 3-Aminocarbazole For the Treatment of a Disorder Associated With the Production of Prostaglandin E2 (Pge2) |
11/20/2008 | US20080287510 Novel compounds as cannabinoid receptor ligands |
11/20/2008 | US20080287498 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
11/20/2008 | US20080287496 1-Oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels |
11/20/2008 | US20080287494 Transmucosal treatment methods in patients with mucositis |
11/20/2008 | US20080287492 Alkylpyridyl Quinolines as Nk3 Receptor Modulators |
11/20/2008 | US20080287480 Therapeutic Combination Comprising a Nmda Receptors Blocker and a Narcotic Analgesic Substance |
11/20/2008 | US20080287478 Nociceptin Analogues and Uses Thereof |
11/20/2008 | US20080287477 Novel Compounds as Modulators of Ppar |
11/20/2008 | US20080287469 Phosphoinositide 3-Kinase Inhibitors for Inhibiting Leukocyte Accumulation |
11/20/2008 | US20080287468 Purine and imidazopyridine derivatives for immunosuppression |
11/20/2008 | US20080287466 4-amino-2,3-disubstituted thieno [2,3,d]pyrimidines and pharmaceutical compositions thereof |
11/20/2008 | US20080287444 Pyrazole compounds useful as protein kinase inhibitors |
11/20/2008 | US20080287416 Organic Compounds |
11/20/2008 | US20080287415 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
11/20/2008 | US20080287398 Cold menthol receptor-1 antagonists |
11/20/2008 | US20080287397 Pyrrolopyrimidine Derivatives Substituted with Cyclic Amino Group |
11/20/2008 | US20080287390 Pyrazolidinol compounds |
11/20/2008 | US20080287385 Inhibitor oligonucleotides and their use for specific repression of a gene |
11/20/2008 | US20080286806 Ligand for G-protein coupled receptor GPR43 and uses thereof |
11/20/2008 | US20080286363 (R)-5-[2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one maleate; 3-[(Cyclopentyl-hydroxyphenylacetyl)oxy]-1,1-dimethylpyrrolidinium bromide (glycopyrrolate), and a glucocorticosteroids |
11/20/2008 | US20080286362 mixture of non-aggregated isooctyltrimethoxysilane modified silica nanoparticle and solid bulk material in the form of a powder, containing a drug; free flowing; use in inhalation device |
11/20/2008 | US20080286344 Film to encapsulate pharmaceutical, agrochemical, detergent active ingredients; fill material less compacted than in a tablet but more than in a capsule; controlled release; fewer, lower quantities of excipients |
11/20/2008 | US20080286343 Solid form |
11/20/2008 | US20080286296 Cyclic-Dinucleotides and Its Conjugates as Adjuvants and Their Uses in Pharmaceutical Compositions |
11/20/2008 | US20080286288 Vascular endothelial growth factor 2 |
11/20/2008 | US20080286266 Novel Use of Il-1Beta Compounds |
11/20/2008 | US20080286213 Comprising morusin, Cortex Mori (White Mulberry root-bark), for use in manufacturing antibacterial medicaments or oral care products; treatment of caries and periodontal disease |
11/20/2008 | CA2687303A1 ((phenyl)imidazolyl)methylheteroaryl compounds |
11/20/2008 | CA2686903A1 Substituted imidazopyridazines and pyrrolopyrimidines as lipid kinase inhibitors |
11/20/2008 | CA2686517A1 Azetidine derivatives and their use as prostaglandin e2 antagonists |
11/20/2008 | CA2686385A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk |
11/20/2008 | CA2686091A1 New compounds |
11/20/2008 | CA2684932A1 Substituted imidazopyridazines as pi3k lipid kinase inhibitors |
11/19/2008 | EP1992356A2 Rapamycin and IL-10 for the treatment of immune diseases |
11/19/2008 | EP1992355A1 Pharmaceutical combination medication comprising NSAIDs or cytoxic drugs |
11/19/2008 | EP1992338A2 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
11/19/2008 | EP1992335A1 Spray drying methods and compositions thereof |
11/19/2008 | EP1991554A1 Thiopyrophosphate organic compounds, method for preparing thereof and compositions containing them |
11/19/2008 | EP1991550A1 Amino pyrimidine compounds for the treatment of inflammatory disorders |
11/19/2008 | EP1991251A1 Use of tlr3 agonists for the treatment of neurodegenerative disorders |
11/19/2008 | EP1648484B1 Formulations for the treatment of arhritis conditions |
11/19/2008 | EP1613288B1 Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol |
11/19/2008 | EP1453539B1 Immunotherapeutic methods and systems |
11/19/2008 | EP1448545B1 Nf-kb inhibitors |
11/19/2008 | EP1343529B1 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
11/19/2008 | EP1272169B1 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
11/19/2008 | EP0802921B1 Human pak65 |
11/19/2008 | CN101309925A Fused tetracyclic mglur1 antagonists as therapeutic agents |
11/19/2008 | CN101309915A Compounds and compositions as lxr modulators |
11/19/2008 | CN101309707A Compositions comprising lipoxygenase inhibitors and cyclodextrin |
11/19/2008 | CN101309683A Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases |
11/19/2008 | CN101309601A High-potency sweetener composition with an anti-inflammatory agent and compositions sweetened therewith |
11/19/2008 | CN101307345A Method for preparing ebosin |
11/19/2008 | CN101307094A Novel nuclear factor ¿Ckappa B p65 subunit antagonizing polypeptide |
11/19/2008 | CN101307017A Amino-methyl substituted tetracycline compounds |
11/19/2008 | CN101306191A Use of TLR2 ligand PGN in treating metabolism syndrome |
11/19/2008 | CN101306181A Elemene fat emulsion injection and preparation method thereof |
11/19/2008 | CN101306174A Medicine for treating woman's dysmenorrhea and preparation method thereof |
11/19/2008 | CN101306151A Traditional Chinese drug composition for treating injuries from falls |
11/19/2008 | CN101306146A Hog compression drug for treating trigeminal neuralgia |
11/19/2008 | CN101306134A Compound Nanxing pain paste and cataplasm combination and its preparation method |
11/19/2008 | CN101306133A Oral liquid for anti-AIDS |
11/19/2008 | CN101306116A Xinnaoqingyu decoction |
11/19/2008 | CN101306112A Baimaiyutong paster |
11/19/2008 | CN101306073A Formulation for treating rheumatism arthralgia syndrome |
11/19/2008 | CN101306027A Extracting method of medical mangrove acanthus total flavonoids |
11/19/2008 | CN101306008A Use of Yibosu in preparing analgesics |
11/19/2008 | CN101306007A Use of Yibosu in preparing medicine for treating rheumatoid arthritis |
11/19/2008 | CN101306003A Use of cyaniding 3-0 glucoside in preparing medicament or food for preventing and curing atrophic arthritis |
11/19/2008 | CN101305982A 局部凝胶给药体系 Topical gel delivery system |
11/19/2008 | CN101305975A Health preservation feet bath bag |
11/19/2008 | CN101305780A Multi-flavor long-acting noodles for preventing and treating cold and its production method |
11/19/2008 | CN100434519C Curing and preventing method |
11/19/2008 | CN100434436C NO donor-type hydrocortisone derivative, its preparing method and antiphlogistic use |
11/19/2008 | CN100434421C Substituted propane-1,3-diamine derivatives and the pharmaceutical use |
11/19/2008 | CN100434084C Pharmaceutical composition for treating rheumatic and rheumatoid diseases and its preparation process |
11/19/2008 | CN100434072C Medication of possessing function of anti inflammation, for improving rheological property of blood, and restraining thrombosis |
11/19/2008 | CN100434070C Externally applied ointment of ketorolac tromethamine and its preparation method |
11/18/2008 | US7453006 Inositol derivatives for increasing chloride secretion and inhibiting inflammation |
11/18/2008 | US7452977 Antibody to a kinase capable of site-specific phosphorylation of IκBα |
11/18/2008 | US7452976 Immunoglobulin specific to kinase insert domain-containing receptor (KDR) for use in treatment and prevention of inflammation, psoriasis, rheumatoid arthritis and tumor growth; immunotherapy |
11/18/2008 | US7452912 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
11/18/2008 | US7452905 Phenylalanine derivatives |
11/18/2008 | US7452890 Substituted pyrazoles |
11/18/2008 | US7452886 E.g., 6-(6-Chloro-pyridin-3-yloxymethyl)-7-(2,2-dimethyl-propyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; in particular, cathepsin K inhibitors; osteoporosis; oral, autoimmune and respiratory diseases; osteoarthritis; antiarthritic and antitumor agents; muscular dystrophy; amytrophy; parasiticides |